Dr. Shunbin Ning is an associate professor in the Department of Internal Medicine, East Tennessee State
University, USA. He is interested in the interaction between chronic viral infections and the host innate
immune system, with focus on type I IFN-mediated innate immune system, DNA damage response,
autophagy, and oxidative stress. The long-term goal of these studies is to identify molecular targets for
immunotherapeutic and antiviral therapeutic applications.
) Department of Internal Medicine Quillen College of Medicine East Tennessee State University Johnson City, TN USA
Dr. Rusliza Basir is currently an Associate Professor at the Faculty of Medicine & Health
Sciences, Universiti Putra Malaysia. She received her Bachelor of Science (BSc. Hons) degree
in Pharmacology from the University of Liverpool, UK in 1994 and Doctor of Philosophy (PhD) in
Immunopharmacology from the University of Manchester, UK in 1998. Her research is focus
mainly on the immunopharmacological aspects of malaria and targeting the immune system for
immunotherapeutic development for the infection. She has more than 80 refereed publications
in reputable journals and has presented her research works at many conferences nationally and
Dr. Burbano holds a degree in Biomedicine from the Federal University of Pará (1989), a master's degree (1993) and a PhD in Biological Sciences (Genetics) from the Ribeirão Preto Medical School of the University of São Paulo (1998). He completed his post-doctorate in Morphology at the Discipline of Genetics at the Escola Paulista de Medicina of the Federal University of São Paulo in 2005. He is a Full Professor at the Federal University of Pará. He works in the area of Human Genetics, Cell Biology and Oncology. He is currently the Coordinator of the Molecular Biology Laboratory at Hospital Ophir Loyola, Belém, Pará.
) Federal University of Pará Hospital Ophir Loyola Belém, Pará Brazil
Dr. Shirzad Fallahi is Associate Professor of Medical Parasitology at Lorestan University of Medical
Sciences West of Iran. He graduated from Shahid Beheshti University of Medical Sciences, Tehran, Iran
in 2014 with a PhD in Medical Parasitology. He has 50 research papers on different parasitic and
microbial diseases. His research interests include molecular diagnosis of infections, new molecular
techniques, epidemiology of infectious and parasitic diseases, and molecular diagnosis of protozoa
important in medicine. He is currently exploring new diagnostic techniques for rapid, accurate and cost-
effective Coronavirus disease (COVID-19) diagnosis.
) Department of Parasitology and Mycology Lorestan University of Medical Sciences Khorramabad Iran
U. Haque Department of Biostatistics and Epidemiology University of North Texas Health Science Center Fort Worth, TX USA
Dr. Subhash Chandra is an Academic Researcher at the Department of Pharmaceutical Chemistry, Hemvati Nandan Bahuguna Garhwal (A Central) University Srinagar Garhwal-246174, Uttarakhand, India, since March 2010. He has 11 years experience in the fields of Teaching, Research and Industry. He had published many peer reviewed scientific articles (49), books (5) and had presented papers at many National and International conferences (42). As a seasoned researcher he had published an Indian “Patent” on Antidibetic herbal tablet from high-altitude medicinal plant of Indian Himalayan region. Moreover, as an analyst, he is keenly interested in the area of Nutraceutical, Phytochemistry, Herbal Formulation, Natural Product Research, Drug Delivery System and Analytical Methods. He has achieved Eminent, Emerging and Young Scientist award in Pharmaceutical Research-2020 and Young Scientist Award-2016 & 15 and 2012.
Professor (Dr.) Shyamapada
Mandal, attached to the Department of Zoology, University of Gour Banga, Malda (India) since
2011. His research interest includes infectious diseases including COVID-19 and
coronaviruses, molecular epidemiology of infectious diseases, drug
resistances, public health, and biomedicine including probiotics. Seven national academic and
research awards have been conferred to him. Published more than 100 articles/chapters/reviews.
Reviewer of many scientific papers in the field of Biomedicine, and editorial board members of
seven biomedical journals. Awarded PhD (Science) in 2006,
from the School of Tropical Medicine (Jadavpur University), India.
Veterinarian graduated from the Fluminense Federal University, Technologist in Public Health of the
Instituto Oswaldo Cruz/FIOCRUZ. Started academic career as a Scientific Initiation/CNPq student in
1997, Master and Doctor in the Cellular and Molecular Biology Program, with an emphasis on
Immunology at the Instituto Oswaldo Cruz. At the Federal University of São Paulo, completed pos-doc
in the Clinical Nephrology Discipline at Escola Paulista de Medicina / UNIFESP.
Dr. Muhammad Amin Ph.D., is Associate Professor of Department of Chemistry, University of Sargodha, Pakistan. His research area includes Nanochemistry, Computational Chemistry, Drug design and discovery, Biophysical chemistry. The goal is to design and discover pharmaceutical agents/Vaccines for contagious viruses by studying the theoretical aspects of virus entry to host cells and drug interaction at viral-host protein interfaces. In the context of ongoing pandemic COVID-19, I have an honor to publish my research related to drug-design, development and repurposing of FDA approved existing medicines for SARS-COV-2 related infections, the mechanisms of viral entry into host cells and genomic studies of novel corona virus.
Simone Brogi is an Assistant Professor at the Department of Pharmacy at University of Pisa (Italy). He leads the Computational Pharmacology and Toxicology Unit in the research group of Prof. Vincenzo Calderone. He graduated in 2005 in Biological Sciences from the University of Siena (Italy), where he also received his Ph.D. in Pharmaceutical Sciences in 2010. From 2011 to 2019 he directed the Molecular Modeling Unit at the Department of Biotechnology, Chemistry and Pharmacy (University of Siena) in the research group of Prof. Giuseppe Campiani. His research activity is focused on computational approaches in drug discovery.
Dr. Cheng Cheng is currently the group leader for HIV vaccine at Virology Lab, Vaccine Research Center, NIAID/NIH. Dr. Cheng received a PhD from Nagoya University and postdoctoral training at University of Washington. He joined the Vaccine Research Center in 2003 and has developed vaccines for HIV and Ebola. He received NIH director award for the development of cAd3-ZEBOV vaccine (2015) and NIAID merit award for fusion peptide based HIV vaccine (2019). He had worked as Lab head at Novartis Pharmaceuticals. He has 7 issued patents and published papers in Cell, Nature Medicine, Nature Communications and Immunity.
Dr. FIRINU serves in the Department of Internal medicine, Allergy and
Clinical Immunology, managing the diagnostic and therapeutic
processes of adults with complex diseases in inpatient and outpatient
care settings. He focused his research interests on three main fields:
autoimmunity/rheumatology, primary immunodeficiencies and rare
diseases associated with dysregulation of immunity.
Additional fields of interest are the innate and acquired responses to
fungal infectious diseases and the genetic regulation of the immune
system. Since 2013, he has been a representative of Biologicals Interest
Group, at European Academy of Allergy and Clinical Immunology
) Department of Internal medicine, Allergy and Clinical Immunology University of Cagliari Cagliari Italy
Professor Eduard Karamov is serving as the Head of Laboratory of Immunochemistry at the Gamaleya Center, Russia. Dr. Karamov graduated from the Lomonosov University of Moscow, Russia. He earned his PhD degree from the Ivanovsky Research Institute of Virology, Russia in 1974. His research is focused on HIV antivirals, microbicides, HIV vaccine, molecular epidemiology of HIV, HIV/TB coinfection, SARS-CoV-2 antivirals, virucidal agents and nanomaterials. Over the last three decades, Dr. Karamov has served as an expert of a number of international organizations.
) Gamaleya National Research Center for Epidemiology and Microbiology Moscow Russian Federation
Professor Hu’s research interests are in molecular basis of regulated cell death, apoptosis, autophagy,
necroptosis, ferroptosis, and pyroptosis, in human diseases, for example, SARS-CoV-2 infection and
COVID-19. ResearchGate: https://www.researchgate.net/profile/Chien_An_Andy_Hu
) Department of Biochemistry and Molecular Biology University of New Mexico School of Medicine and Health Sciences Center Albuquerque, NM United States
D. Kouretas Department of Biochemistry-Biotechnology University of Thessaly Larisa Greece
Dr. L Keith Scott is an adult and pediatric intensivist and director of the SICU at LSU Health in
Shreveport. Dr. Scott has parCcular experCse in ECMO having performed that procedure for more than
20 years. Also, he is former Chief of the CVICU at Wake Forest University. Currently he is Professor of
Pediatrics, Surgery and Medicine at LSU Health. Dr. Scott also holds a master degree in Global Health
and infecCous Diseases from the University of Edinburgh and is acCve in developing ICU care models
in HaiC and parts of rural Africa.
) Adult and Pediatric CF Center Louisiana State University Shreveport, LA USA
H. Xu School of Pharmacy Shanghai University of Traditional Chinese Medicine Shanghai China
She works at the Medical Faculty of Tunis, Tunisia as associate
professor in Public Health and head of the epidemiology and statistics department in A. Mami
hospital from November 2016 to March 2019. She is a graduate from the France Field
Epidemiology Training Programme in 2011. She has 8 years of experience in university teaching
and research leading. She was the head of the international surveillance unit at the Tunisian
National Observatory of New and Emerging Diseases for one year, a head of department, has
conducted research at household, community, health facility, district and ecological studies and
published more than 30 papers. She is a member of several technical working groups at
Ministry of Health such as lymph nodes tuberculosis prevention group and “Early Warning and
Response” Curriculum development pedagogy committee. She has supervised more than 20
students at Masters level and thesis.
Dr. Petra Obioma Nnamani is currently Humboltian at Helmholtz-Institute for
Pharmaceutical Research Saarland (HIPS), Saarland University Germany, and also
Senior lecturer at the Department of Pharmaceutics, University of Nigeria, Nsukka
(UNN). She obtained her B.Pharm (2001) and M.Pharm (2004) both from UNN. Petra
joined the nanotechnology group at ICS-UNIDO (Trieste Italy, 2009) for Early Research
Training in Nanotechnology and later obtained her PhD in Drug Delivery (2010) from
UNN. She was CV Raman International Fellow at the Department of Physics, Shivaji University Kolhapur, India (2012) and TWAS-DFG Cooperation Visits Programme at
HIPS (2013). Petra is a Member of NYAS, OWSD and PSN.
Dr. Alexsandro Galdino received Biological Sciences degree from Universidade Federal do Ceará (Brazil) and obtained a doctoral degree from the Universidade de Brasília (UnB) (Brazil). He has conducted post-doctoral research in UnB (2008-2010) and has been professor in Universidade Federal de São João Del-Rei (Brazil) since 2010. During his studies, Dr. Galdino dedicates efforts in the field of cloning and heterologous gene expression in microorganisms (bacteria and yeasts) to obtain innovative products for industries. Dr. Galdino produces recombinant industrial enzymes for several biotechnological applications as well as antigenic targets as input for immunological diagnosis kits.
) Federal University of São João Del-Rei (UFSJ) Microbial Biotechnology Laboratory Divinopolis Brazil